CAU
MD icon

Caxton Associates (UK)’s Pediatrix Medical MD Stock Holding History

Caxton Associates (UK)’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-58,318
Closed -$1.25M – 918
2025
Q4 		$1.25M Buy
58,318
+26,733
+85% +$548K 0.02% 308
2025
Q3 		$529K Buy
31,585
+15,167
+92% +$227K 0.01% 448
2025
Q2 		$236K Buy
+16,418
New +$225K 0.01% 600

Other funds holding MD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Caxton Associates (UK)'s MD Position: Q1 2026 in Review

Caxton Associates (UK) sold out of Pediatrix Medical (MD) in Q1 2026, closing a stake of 58,318 shares — an estimated $1.25M sold.

Caxton Associates (UK) first reported a position in MD in Q2 2025 and held it in 3 quarters. The position peaked at $1.25M in Q4 2025. 297 funds tracked by Wall St. Rank hold MD as of Q1 2026.

  • Caxton Associates (UK) reported no remaining Pediatrix Medical position as of Q1 2026 after selling out during the quarter.
  • Caxton Associates (UK) sold 58,318 Pediatrix Medical shares in Q1 2026, an estimated $1.25M.
  • Caxton Associates (UK) first reported a position in Pediatrix Medical in Q2 2025 and held it in 3 quarters.
  • Caxton Associates (UK)'s Pediatrix Medical position peaked at $1.25M in Q4 2025.
  • 297 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.

Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.